H3K27M cell-free tumor DNA tracking in response to ONC201 treatment for diffuse midline glioma

from Neuro-Oncology: The Podcast · host Dr. Iyad Alnahhas, Dr. Carl Koschmann

Dr. Iyad Alnahhas interviews Dr. Carl Koschmann about his and his team's recent manuscript entitled: "Serial H3K27M cell-free tumor DNA (cf-tDNA) tracking predicts ONC201 treatment response and progression in diffuse midline glioma" published online in Neuro-Oncology in February 2022. Read the Study

Episode metadata supplied by the publisher feed · Published Mar 25, 2022

Embed this episode

Attribution link and audio player

NOW PLAYING

H3K27M cell-free tumor DNA tracking in response to ONC201 treatment for diffuse midline glioma

0:00 22:02

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Neuro-Oncology: The Podcast?

This episode is 22 minutes long.

When was this Neuro-Oncology: The Podcast episode published?

This episode was published on March 25, 2022.

Can I download this Neuro-Oncology: The Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!